BVS compared with MDXG: revenue, margins and what each company keeps, and the suppliers and customers both name

BVSBioventus Inc.

Mkt capRevenueRevenue

MDXGMimedx Group, Inc.

Mkt capRevenueRevenue

Compare

BVSBioventus Inc.

MDXGMimedx Group, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

BVS

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q3 FY26—▼−16.77%—

Q2 FY26±19.9%▲+13.71%×0.69

May 6 '26±17.1%▲+2.25%×0.13

Q1 FY26±17.5%▲+7.44%×0.42

MDXG

0 of 2at or beyond implied

Reportimpliedrealized× implied

Q3 FY26—▲+0.51%—

Q2 FY26±39.8%▲+0.95%×0.02

= impliedBVS realized, solidMDXG realized, hatchedOne scale, both sides: full bar = 40%× = |realized| ÷ impliedSource: market data

Q1 FY26

—

▲+8.91%

—

Feb 26 '26±13.3%▼−6.44%×0.48

BVSBioventus Inc.

10.61▼−0.66%· post 10.61

Mkt cap$894.0MRevenue$142MQ3 FY26Revenue$568MFY25

MDXGMimedx Group, Inc.

3.32▲+1.26%· post 3.32

ClosedNov 6 '26

Mkt cap$483.0MRevenue$62MQ3 FY26Revenue$419MFY25

Compare

ClosedNov 6 '26

BVSBioventus Inc.

MDXGMimedx Group, Inc.

10.61▼−0.66%post 10.61

Price

3.32▲+1.26%post 3.32

$894.0M

Mkt cap

$483.0M

Q3 FY26$142M

Revenue

$62MQ3 FY26

FY25$568M

Revenue

$419MFY25

BVS10.61▼−0.66%vsMDXG3.32▲+1.26%ClosedNov 6 '26